Barclays PLC Sells 1,325,531 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Barclays PLC lessened its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 47.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,477,392 shares of the company's stock after selling 1,325,531 shares during the quarter. Barclays PLC owned approximately 0.32% of GE HealthCare Technologies worth $115,502,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in GEHC. Vanguard Group Inc. raised its stake in GE HealthCare Technologies by 4.3% during the fourth quarter. Vanguard Group Inc. now owns 52,537,446 shares of the company's stock worth $4,107,378,000 after buying an additional 2,155,429 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of GE HealthCare Technologies by 3.1% during the 4th quarter. Geode Capital Management LLC now owns 11,320,576 shares of the company's stock valued at $882,777,000 after purchasing an additional 342,819 shares in the last quarter. Invesco Ltd. grew its stake in GE HealthCare Technologies by 18.4% during the fourth quarter. Invesco Ltd. now owns 8,067,927 shares of the company's stock worth $630,751,000 after purchasing an additional 1,252,613 shares during the period. Norges Bank bought a new stake in GE HealthCare Technologies in the fourth quarter worth approximately $488,531,000. Finally, Van ECK Associates Corp lifted its stake in GE HealthCare Technologies by 107.3% in the fourth quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company's stock valued at $378,520,000 after buying an additional 2,506,417 shares during the period. 82.06% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on GEHC shares. Citigroup lifted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research note on Thursday, February 13th. BTIG Research set a $95.00 price objective on shares of GE HealthCare Technologies and gave the company a "buy" rating in a report on Monday, April 14th. Wells Fargo & Company raised their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research note on Friday, February 14th. Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their price target for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, The Goldman Sachs Group upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $85.00 to $100.00 in a report on Tuesday, March 11th. One research analyst has rated the stock with a sell rating, two have given a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of "Moderate Buy" and a consensus price target of $97.27.

GE HealthCare Technologies Stock Up 1.4 %

GE HealthCare Technologies stock traded up $0.89 during midday trading on Friday, hitting $62.37. 4,471,392 shares of the stock were exchanged, compared to its average volume of 3,181,911. The stock has a market capitalization of $28.56 billion, a price-to-earnings ratio of 14.40, a price-to-earnings-growth ratio of 3.19 and a beta of 1.14. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The business's 50-day moving average price is $79.26 and its 200-day moving average price is $83.09. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be issued a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.22%. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.23%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.